Approval · Notice of Compliance 1544 · 2000
BRICANYL TABLETS: Notice of Compliance 1544
Issued May 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1544
- Date
- May 1, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRICANYL TABLETS | 00335355 | Cancelled Post Market |
| BRICANYL TABLETS | 00335363 | Cancelled Post Market |
Medicinal ingredients
- TERBUTALINE SULFATE 2.5 MG per TAB
- TERBUTALINE SULFATE 5 MG per TAB